Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Barclays' Rating of Lumexa Imaging on 5/20/2026

On May 20, 2026, Barclays updated its outlook on Lumexa Imaging (NASDAQ:LMRI) with the action "Lower Price Target", setting a price target of $9.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Barclays PLC

DateCompanyAction
5/20/2026
Keysight Technologies Inc. stock logo
KEYS
Keysight Technologies
Boost Price Target
5/20/2026
Bally's Corporation stock logo
BALY
Bally's
Reiterated Rating
5/20/2026
KE Holdings Inc. Sponsored ADR stock logo
BEKE
KE
Reiterated Rating
5/20/2026
CAVA Group, Inc. stock logo
CAVA
CAVA Group
Boost Price Target
5/20/2026
SentinelOne, Inc. stock logo
S
SentinelOne
Boost Price Target
5/19/2026
Barratt Redrow plc. stock logo
BTDPY
Barratt Redrow
Downgrade
More Ratings From Barclays PLC